BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS
Product details
Registration number: SIN13822P
Classification: General Sale List
Active ingredients: Sodium Bicarbonate
Strength: 100%
Dosage form: POWDER, FOR SOLUTION
Route: EXTRACORPOREAL
Registrant: FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
ATC code: Not recorded in this imported record.
HSA approval date: 2 July 2010
Manufacturer(s): Fresenius Medical Care SMAD
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13822P
Classification: General Sale List
What active ingredients and strength are recorded for BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Sodium Bicarbonate
Strength: 100%
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SOLUTION
Route: EXTRACORPOREAL
Who is the recorded registrant for BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Fresenius Medical Care SMAD
Manufacturing country/countries: FRANCE
Where can I look up BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13822P or the exact product name BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS. The general register link does not preselect this product.
What are the source dates for this BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BIBAG (5008 DESIGN) POWDER FOR HAEMODIALYSIS record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13822P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)